Department of Biochemistry and Molecular Biology, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA; Department of Pediatric and Adolescent Medicine, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA.
Department of Immunology, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA.
Cancer Cell. 2023 Jul 10;41(7):1261-1275.e6. doi: 10.1016/j.ccell.2023.05.006. Epub 2023 Jun 1.
Senescent cells play relevant but context-dependent roles during tumorigenesis. Here, in an oncogenic Kras-driven lung cancer mouse model, we found that senescent cells, specifically alveolar macrophages, accumulate early in neoplasia. These macrophages have upregulated expression of p16 and Cxcr1, are distinct from previously defined subsets and are sensitive to senolytic interventions, and suppress cytotoxic T cell responses. Their removal attenuates adenoma development and progression in mice, indicating their tumorigenesis-promoting role. Importantly, we found that alveolar macrophages with these properties increase with normal aging in mouse lung and in human lung adenocarcinoma in situ. Collectively, our study indicates that a subset of tissue-resident macrophages can support neoplastic transformation through altering their local microenvironment, suggesting that therapeutic interventions targeting senescent macrophages may attenuate lung cancer progression during early stages of disease.
衰老细胞在肿瘤发生过程中发挥相关但具有上下文依赖性的作用。在这里,在致癌 Kras 驱动的肺癌小鼠模型中,我们发现衰老细胞,特别是肺泡巨噬细胞,在肿瘤早期积累。这些巨噬细胞上调了 p16 和 Cxcr1 的表达,与先前定义的亚群不同,并且对衰老细胞溶解干预敏感,并抑制细胞毒性 T 细胞反应。去除它们可减轻小鼠中的腺瘤发育和进展,表明它们具有促进肿瘤发生的作用。重要的是,我们发现具有这些特性的肺泡巨噬细胞随着小鼠肺部的正常衰老以及人肺原位腺癌而增加。总的来说,我们的研究表明,一组组织驻留巨噬细胞可以通过改变其局部微环境来支持肿瘤转化,这表明针对衰老巨噬细胞的治疗干预可能会在疾病的早期阶段减轻肺癌的进展。
Cancer Cell. 2023-7-10
Cancer Cell. 2023-7-10
Front Endocrinol (Lausanne). 2022
Nat Rev Cancer. 2025-8-14
Nat Aging. 2025-8
Nat Aging. 2025-8
JCO Clin Cancer Inform. 2025-8
Int J Biol Sci. 2025-6-23
Nat Rev Cancer. 2025-8-4
Nat Commun. 2022-6-28
Nat Rev Cancer. 2022-6
Cancer Discov. 2022-1
Nat Aging. 2021-10
Front Cell Dev Biol. 2021-9-27
Front Immunol. 2021